The Medicines and Healthcare products Regulatory Agency (MHRA) approved Mounjaro for type 2 diabetes in October 2022, and the National Institute for Health and Care Excellence (NICE) has issued guidance on its use within the NHS for both diabetes (TA870) and weight management (TA906), subject to specific eligibility criteria
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways How long you stay on Ozempic depends on your health goals, tolerance of side effects, and your providers guidance
Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial
Other medicines available include amantadine, which increases dopamine release and blocks cholinergic receptors
People currently taking Ozempic likely have a more pressing question on their minds: Should I switch to Mounjaro
Do you ever feel super tired even after a good nights sleep and have trouble finding energy to get through the day